BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Link Technologies Ltd Release: Unlocking the Potential of Cell Delivery Agents


9/27/2013 10:10:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELLSHILL, SCOTLAND, 27 September 2013: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will be presenting a poster at the upcoming 9th Annual Meeting of the Oligonucleotide Therapeutic Society (OTS), 6-8 October, Naples, Italy. The poster entitled ‘New Potential Oligonucleotide Delivery Reagents’, details how Link Technologies’ novel modifiers can enable the enhanced delivery of oligos for therapeutic effect. Inspired by their existing collection of lipophilic modifiers, which have been proven to enhance cell penetration, Link Technologies has developed this new collection of modified phosphoramidites, and are inviting collaborative partners to help discover their full application potential. At OTS, Dr Catherine McKeen, Technical Manager at Link Technologies, will be on-hand throughout the poster presentation sessions to provide further information and answer any questions.

For more information on Link Technologies and our enabling lipophilic modifiers for cell delivery, please attend our poster presentation at OTS or request a free copy of our 2013/14 Product Guide. Providing comprehensive information for scientists working with modified oligos, including validated protocols and supporting application notes, the new product guide is an ideal go-to resource for oligonucleotide chemistry.

Alternatively, please visit the website at www.linktech.co.uk or follow us on Twitter: @linktechdna.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector. Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see: www.linktech.co.uk.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES